Are drug companies keeping tabs on each other?
Pharmaceutical companies are keeping a watchful eye on their rivals and the access to marketing authorizations of other companies reveal highly useful information. But drug companies are not lining up to admit to this practice, records of the companies’ access to documents reveal.
by Benjamin Werner Christensen
Useful information can be hidden in the marketing authorizations of rival pharmaceutical companies, but it is difficult to gauge exactly how big a role access to documents play in the industry, as drug companies are somewhat reluctant to reveal just how often they ask for access to rivals’ marketing authorization.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
